HHS Buys Additional Vaccine as Preparations for Potential Influenza Pandemic Continue

Article

HHS Secretary Mike Leavitt announced last week the purchase of additional vaccine that could be used in the event of a potential influenza pandemic.

The department has awarded a $62.5 million contract to Chiron Corporation to manufacture an avian influenza vaccine designed to protect against the H5N1 influenza virus strain, which has caused an epidemic of avian flu in Asia and has recently spread to Europe. The number of individuals who could be protected by the newly contracted vaccine is still to be determined by ongoing clinical studies.

An influenza vaccine effective against the H5N1 virus is our best hope of protecting the American people from a virus for which they have no immunity, Leavitt said. This contract will increase our stockpile of the vaccine and is a continuation of our aggressive multi-pronged approach to a potentially critical public health challenge.

This purchase builds on the departments current plans to buy enough H5N1 influenza vaccine for 20 million people and enough influenza antivirals for another 20 million people. These supplies of vaccine and antiviral treatment will be placed in the nations Strategic National Stockpile where they will be available for use should an influenza pandemic occur. Last month, HHS awarded a $100 million contract to sanofi pasteur, the vaccines business of the sanofi-aventis Group, for avian flu vaccine.

Developing an effective avian influenza vaccine is a key element of a comprehensive U.S. approach to prepare for an influenza pandemic that includes improved vaccine production methods and stockpiling of antivirals.

Earlier this year, Leavitt established an HHS-wide Influenza Task Force to coordinate all HHS activities affecting the public health preparedness for seasonal influenza outbreaks and an influenza pandemic. Long-term objectives include an effective and efficient global surveillance network for outbreaks of influenza-like illness in humans and animals, and interoperable local, state, and federal government response plans for influenza outbreaks within the United States. The task force is also developing strategies to effectively coordinate with response partners, both public and private and insure timely communication with the public.

Source: HHS

 

 

Recent Videos
Pathogen Playbook Presenter: Sharon Ward-Fore, BS, MS, MT(ASCP), CIC, FAPIC
Mark Wiencek, PhD
Rebecca Crapanzano-Sigafoos, DrPH, CIC, AL-CIP, FAPIC
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Related Content